Literature DB >> 12145097

Role of mitogen-activated protein kinase family in serum-induced leukaemia inhibitory factor and interleukin-6 secretion by bone marrow stromal cells.

Takafumi Nakao1, Shokei Kim, Kensuke Ohta, Hitomi Kawano, Masayuki Hino, Katsuyuki Miura, Noriyuki Tatsumi, Hiroshi Iwao.   

Abstract

1: In the haematopoietic microenvironment, bone marrow stromal cells play an important role in regulating haematopoiesis by expressing various cytokines, including leukaemia inhibitory factor (LIF) and interleukin-6 (IL-6). However, the intracellular signal that regulates cytokine secretion in bone marrow stromal cells has not been determined. The aim of this study was to evaluate the role of mitogen-activated protein kinase (MAPK) family in serum-induced secretion of LIF and IL-6 by bone marrow stromal cells. 2: Transformed human bone marrow stromal cells (HS-5) were stimulated with foetal calf serum (FCS) to produce LIF and IL-6. FCS also induced activation of extracellular signal-regulated kinase (ERK), p38 MAPK and c-Jun NH(2)-terminal kinase (JNK). 3: Both PD98059 (MAPK/ERK kinase inhibitor) and SB203580 (p38 MAPK inhibitor) attenuated FCS-induced LIF protein production and gene expression. SB203580 decreased IL-6 production and gene expression, but PD98059 had no effect on IL-6 production and gene expression. 4: Expression of a dominant-negative mutant form of JNK1 that blocked FCS-induced JNK activity had no effect on protein production and gene expression of these cytokines. 5: These findings demonstrate that both ERK and p38 MAPK are involved in FCS-induced LIF secretion, whereas only p38 MAPK is important for IL-6 secretion, and that FCS-induced activation of JNK has no effect on the production of LIF and IL-6. We conclude that, in spite of their similar biological effects, they are differentially regulated at the level of MAPK activity in bone marrow stromal cells.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12145097      PMCID: PMC1573426          DOI: 10.1038/sj.bjp.0704797

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  42 in total

1.  A secreted and LIF-mediated stromal cell-derived activity that promotes ex vivo expansion of human hematopoietic stem cells.

Authors:  C C Shih; M C Hu; J Hu; Y Weng; P J Yazaki; J Medeiros; S J Forman
Journal:  Blood       Date:  2000-03-15       Impact factor: 22.113

2.  Spontaneous and inducible production of leukaemia inhibitory factor by human bone marrow stromal cells.

Authors:  V Lorgeot; F Rougier; P Fixe; E Cornu; V Praloran; Y Denizot
Journal:  Cytokine       Date:  1997-10       Impact factor: 3.861

3.  The role of p38 mitogen-activated protein kinase in IL-6 and IL-8 production from the TNF-alpha- or IL-1beta-stimulated rheumatoid synovial fibroblasts.

Authors:  M Suzuki; T Tetsuka; S Yoshida; N Watanabe; M Kobayashi; N Matsui; T Okamoto
Journal:  FEBS Lett       Date:  2000-01-07       Impact factor: 4.124

4.  PAF-induced RANTES production by human airway smooth muscle cells requires both p38 MAP kinase and Erk.

Authors:  S Maruoka; S Hashimoto; Y Gon; I Takeshita; T Horie
Journal:  Am J Respir Crit Care Med       Date:  2000-03       Impact factor: 21.405

5.  Bone marrow failure by cytomegalovirus is associated with an in vivo deficiency in the expression of essential stromal hemopoietin genes.

Authors:  A Mayer; J Podlech; S Kurz; H P Steffens; S Maiberger; K Thalmeier; P Angele; L Dreher; M J Reddehase
Journal:  J Virol       Date:  1997-06       Impact factor: 5.103

6.  IL-6 and IL-8 production by human bone marrow stromal cells.

Authors:  F Rougier; E Cornu; V Praloran; Y Denizot
Journal:  Cytokine       Date:  1998-02       Impact factor: 3.861

7.  Direct synergistic effects of leukemia inhibitory factor on hematopoietic progenitor cell growth: comparison with other hematopoietins that use the gp130 receptor subunit.

Authors:  J R Keller; J M Gooya; F W Ruscetti
Journal:  Blood       Date:  1996-08-01       Impact factor: 22.113

Review 8.  Leukemia inhibitory factor: part of a large ingathering family.

Authors:  J L Taupin; V Pitard; J Dechanet; V Miossec; N Gualde; J F Moreau
Journal:  Int Rev Immunol       Date:  1998       Impact factor: 5.311

9.  Impaired cytokine production by bone marrow stromal cells of immunodeficient mice.

Authors:  A W Hamburger
Journal:  Br J Haematol       Date:  1995-08       Impact factor: 6.998

10.  Leukemia inhibitory factor upregulates cytokine expression by a murine stromal cell line enabling the maintenance of highly enriched competitive repopulating stem cells.

Authors:  S J Szilvassy; K P Weller; W Lin; A K Sharma; A S Ho; A Tsukamoto; R Hoffman; K R Leiby; D P Gearing
Journal:  Blood       Date:  1996-06-01       Impact factor: 22.113

View more
  5 in total

1.  DARPP-32 is required for MAPK/ERK signaling in thyroid cells.

Authors:  Ana Chocarro-Calvo; Miguel A Zaballos; Pilar Santisteban; Custodia García-Jiménez
Journal:  Mol Endocrinol       Date:  2012-02-02

2.  Interleukin-6 counteracts therapy-induced cellular oxidative stress in multiple myeloma by up-regulating manganese superoxide dismutase.

Authors:  Charles O Brown; Kelley Salem; Brett A Wagner; Soumen Bera; Neeraj Singh; Ajit Tiwari; Amit Choudhury; Garry R Buettner; Apollina Goel
Journal:  Biochem J       Date:  2012-06-15       Impact factor: 3.857

3.  Combination of the ABL kinase inhibitor imatinib with the Janus kinase 2 inhibitor TG101348 for targeting residual BCR-ABL-positive cells.

Authors:  Seiichi Okabe; Tetsuzo Tauchi; Seiichiro Katagiri; Yuko Tanaka; Kazuma Ohyashiki
Journal:  J Hematol Oncol       Date:  2014-04-28       Impact factor: 17.388

4.  Dual PI3K/mTOR inhibition is required to effectively impair microenvironment survival signals in mantle cell lymphoma.

Authors:  Laia Rosich; Arnau Montraveta; Sílvia Xargay-Torrent; Mónica López-Guerra; Jocabed Roldán; Marta Aymerich; Itziar Salaverria; Sílvia Beà; Elías Campo; Patricia Pérez-Galán; Gaël Roué; Dolors Colomer
Journal:  Oncotarget       Date:  2014-08-30

5.  Effects of Lutein on Hyperosmoticity-Induced Upregulation of IL-6 in Cultured Corneal Epithelial Cells and Its Relevant Signal Pathways.

Authors:  Shih-Chun Chao; Chan-Wei Nien; Codrin Iacob; Dan-Ning Hu; Sheng-Chieh Huang; Hung-Yu Lin
Journal:  J Ophthalmol       Date:  2016-03-07       Impact factor: 1.909

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.